Neko Health, co-founded by Spotify founder Daniel Ek, has raised $700M in series C funding to expand its AI-powered full-body scanning platform to the United States. Lightspeed Venture Partners and O.G. Venture Partners co-led the round, with participation from General Catalyst, Atomico and a list of celebrity investors including Mark Zuckerberg, Maria Sharapova and will.i.am.
Sixty-minute scan, millions of data points
The Neko Health Scan is a 60-minute, radiation-free full-body assessment that uses sensors and blood analysis to collect millions of data points. It evaluates skin health, metabolic health, cardiovascular risk factors, blood abnormalities, body composition and biomarkers signaling pre-diabetes risk. Results are available within minutes, followed by a physician consultation.
Expanding from Europe to the US
The Swedish company currently operates clinics in the UK and Sweden. With this funding, Neko plans to open locations in the US, starting with New York. The company previously raised $260M in series B and $65M in series A.
The funding round reflects growing investor interest in preventive health platforms that combine imaging, biomarker testing and AI analysis to identify disease risk before symptoms emerge.
